Gilles Lacour
Direktor/Vorstandsmitglied bei Bergbahnen Destination GSTAAD AG
Ursprung des Netzwerks ersten Grades von Gilles Lacour
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Bergbahnen Destination GSTAAD AG
 Bergbahnen Destination GSTAAD AG RestaurantsConsumer Services Bergbahnen Destination GSTAAD AG engages in the operation of mountain railways. It manages transport facilities and mountain lodges. The company was founded on May 1, 2003 and is headquartered in Gstaad, Switzerland.
17
| Public Company | Restaurants | 17 |
Auregen Biotherapeutics SA
 Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland.
8
| Holding Company | Packaged Software | 8 |
Commave Therapeutics SA
 Commave Therapeutics SA Pharmaceuticals: MajorHealth Technology Commave Therapeutics SA is a Swiss pharmaceutical manufacturing company. The private company is based in Geneva, Switzerland.
3
| Private Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gilles Lacour
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Auregen Biotherapeutics, Inc.
 Auregen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auregen Biotherapeutics, Inc. provides biotechnology services. The CEO of the American company is Richard John Davies. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| Stallergenes Canada, Inc. | Chairman Director/Board Member | ||
| STALLERGENES GREER | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Basel | College/University | Undergraduate Degree | |
Skylark Bio, Inc.
 Skylark Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Skylark Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| Amgen Australia Pty Ltd. | Corporate Officer/Principal | ||
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Warwick | College/University | Masters Business Admin | |
| University of Portsmouth | College/University | Undergraduate Degree | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Milan | College/University | Doctorate Degree | |
| BONESUPPORT HOLDING AB | Medical Specialties | Chief Executive Officer | |
Affidea BV
 Affidea BV Finance/Rental/LeasingFinance Part of Groupe Bruxelles Lambert SA, Affidea BV is a provider of advanced diagnostic imaging and outpatient services. The company is based in The Hague, the Netherlands. The Dutch company operates 315 centers in 15 countries, managing care to ensure patients receive appropriate, personalized care from leading medical experts. The company was founded in 1991. The CEO is Giuseppe Recchi. | Finance/Rental/Leasing | Chairman | |
Waypoint Group Holdings SA
 Waypoint Group Holdings SA Financial ConglomeratesFinance Waypoint Group Holdings SA is a private investment firm that partners with sophisticated capital to deliver exceptional value over generations while contributing positively to society. The private company is based in Geneva, Switzerland and has offices across the United States. The firm has a proud heritage, having grown from a Swiss biopharmaceutical company over three generations to an investment track-record built over 20 years. | Financial Conglomerates | Director/Board Member | |
Waypoint Funding Gp Ltd.
 Waypoint Funding Gp Ltd. Investment Trusts/Mutual FundsMiscellaneous Waypoint Funding Gp Ltd. operates as a grant making foundation. The private company is based in Saint Helier, UK. | Investment Trusts/Mutual Funds | Director/Board Member | |
| Waypoint Finance Gp Ltd. | Director/Board Member | ||
Waypoint Co-Invest Gp Ltd.
 Waypoint Co-Invest Gp Ltd. Financial ConglomeratesFinance Waypoint Co-Invest Gp Ltd. functions as an investment holding British company. The private company is based in Saint Helier, UK. | Financial Conglomerates | Director/Board Member | |
| Waypoint Civ Gp Ltd. | Miscellaneous | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bone Support Incentive AB
 Bone Support Incentive AB Real Estate DevelopmentFinance Part of BONESUPPORT HOLDING AB, Bone Support Incentive AB provides real estate services. The company is based in Lund, Sweden. | Real Estate Development | Chairman | |
BONE SUPPORT AB
 BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Chief Executive Officer | |
MS Mail Service AG
 MS Mail Service AG Information Technology ServicesTechnology Services MS Mail Service AG provides outsourcing services. The private company is based in St. Gallen, Switzerland. The CEO of the Swiss company is Walter Lüthi. | Information Technology Services | Chief Executive Officer | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| FREELINE THERAPEUTICS HOLDINGS PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Georgetown University School of Medicine | College/University | Doctorate Degree | |
| Georgetown University | College/University | Undergraduate Degree | |
| Autophon AG | Chief Tech/Sci/R&D Officer | ||
| KerrHawe SA | Sales & Marketing | ||
Betty Bossi AG
 Betty Bossi AG Publishing: Books/MagazinesConsumer Services Betty Bossi AG publishes cuisine magazines. | Publishing: Books/Magazines | Chief Executive Officer | |
| Adia Interim AG | Corporate Officer/Principal | ||
| Stiftung SOS-Kinderdorf Schweiz | Director/Board Member | ||
Forestay Capital Management Ltd.
 Forestay Capital Management Ltd. Investment ManagersFinance Part of Forestay Capital SA, Forestay Capital Management Ltd. provides capital management services. The company is based in St. Helier, UK. | Investment Managers | Director/Board Member | |
alipro AG
 alipro AG Food: Specialty/CandyConsumer Non-Durables AliPro AG produces jams, jellies, dessert sauces, and massa bianca products. The private company is based in Hittnau, Switzerland. | Food: Specialty/Candy | Director/Board Member | |
| Büro Schoch Werkhaus AG | Director/Board Member | ||
Artum AG
 Artum AG Financial ConglomeratesFinance Artum AG operates as an investment holding company. It focuses on the acquisition and development of small and medium-sized companies. The company was founded in 2005 and is headquartered in Zurich, Switzerland. | Financial Conglomerates | Chairman | |
| Success Factory AG | Chairman | ||
| ORIOR AG | Food: Meat/Fish/Dairy | Director/Board Member | |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Chairman | |
| ALVOTECH | Biotechnology | Director/Board Member | |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Pharmaceuticals: Major | Director/Board Member | |
Northill UK Management Holdings Ltd.
 Northill UK Management Holdings Ltd. Financial ConglomeratesFinance Part of Landmark LP, Northill UK Management Holdings Ltd. is a holding company. Northill UK Management Holdings Ltd. is based in London, UK. Founded in 2010, Northill UK Management Holdings operates as a holding company. | Financial Conglomerates | Director/Board Member | |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman | |
Chicot Trustee Ltd.
 Chicot Trustee Ltd. Financial ConglomeratesFinance Chicot Trustee Ltd. provides investment services. The private company is based in Saint Helier, UK. | Financial Conglomerates | Director/Board Member | |
WayPoint Capital LLC
 WayPoint Capital LLC Investment ManagersFinance WayPoint Capital LLC provides professional, scientific and technical services. The company was founded in 2011 and is headquartered in Spokane, WA. | Investment Managers | Chief Operating Officer | |
Crosstree Real Estate Management Ltd.
 Crosstree Real Estate Management Ltd. Real Estate DevelopmentFinance Crosstree Real Estate Management Ltd. engages in buying, selling, and managing real estate. The private company is based in St. Helier, UK, and has subsidiaries in the United Kingdom. | Real Estate Development | Director/Board Member | |
| Bemido SA | Director/Board Member | ||
| Waypoint GP Ltd. | Director/Board Member |
Statistik
International
| Schweiz | 16 |
| Vereinigtes Königreich | 15 |
| Vereinigte Staaten | 11 |
| Schweden | 4 |
| Kanada | 2 |
Sektoral
| Health Technology | 14 |
| Finance | 11 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Miscellaneous | 3 |
Operativ
| Director/Board Member | 71 |
| Corporate Officer/Principal | 16 |
| Chairman | 14 |
| Chief Executive Officer | 7 |
| Chief Tech/Sci/R&D Officer | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Gilles Lacour
- Unternehmensverbindungen
